Which statement correctly describes an aspect of a Phase II clinical trial?

A: randomized controlled multicenter trials on large patient groups B: designed to assess the pharmacovigilance, pharmacokinetics, and pharmacodynamics of a drug C: in vitro and in vivo experiments using wide-ranging doses of the drug D: designed to assess how well the drug works